Stephens set a $19.00 price objective on Caretrust REIT (NASDAQ:CTRE) in a report issued on Friday morning. The firm currently has a buy rating on the real estate investment trust’s stock.

Several other brokerages have also issued reports on CTRE. Stifel Nicolaus reiterated a hold rating and issued a $19.00 price target (up previously from $17.00) on shares of Caretrust REIT in a report on Thursday, November 9th. Zacks Investment Research upgraded Caretrust REIT from a sell rating to a buy rating and set a $21.00 price target on the stock in a report on Tuesday, October 24th. BidaskClub lowered Caretrust REIT from a sell rating to a strong sell rating in a report on Tuesday, December 12th. KeyCorp set a $20.00 price target on Caretrust REIT and gave the stock a buy rating in a report on Sunday, October 29th. Finally, Wells Fargo & Co upgraded Caretrust REIT from a market perform rating to an outperform rating and set a $20.00 price target on the stock in a report on Tuesday, December 19th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the stock. The stock presently has an average rating of Hold and a consensus price target of $19.78.

Shares of Caretrust REIT (CTRE) traded down $0.26 during trading hours on Friday, reaching $15.43. The company’s stock had a trading volume of 648,100 shares, compared to its average volume of 645,378. The company has a market capitalization of $1,190.00, a price-to-earnings ratio of 33.54, a P/E/G ratio of 2.37 and a beta of 0.67. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 0.81. Caretrust REIT has a 1-year low of $14.71 and a 1-year high of $19.86.

Caretrust REIT (NASDAQ:CTRE) last announced its quarterly earnings results on Wednesday, November 8th. The real estate investment trust reported $0.28 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.29 by ($0.01). The firm had revenue of $32.90 million during the quarter, compared to the consensus estimate of $32.91 million. Caretrust REIT had a return on equity of 5.76% and a net margin of 25.68%. The firm’s revenue was up 21.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.28 EPS. equities research analysts expect that Caretrust REIT will post 1.16 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 16th. Stockholders of record on Friday, December 29th will be paid a $0.185 dividend. This represents a $0.74 annualized dividend and a dividend yield of 4.80%. The ex-dividend date is Thursday, December 28th. Caretrust REIT’s dividend payout ratio (DPR) is presently 160.87%.

Institutional investors have recently modified their holdings of the company. Riverhead Capital Management LLC raised its stake in shares of Caretrust REIT by 90.7% in the second quarter. Riverhead Capital Management LLC now owns 5,529 shares of the real estate investment trust’s stock worth $103,000 after purchasing an additional 2,629 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Caretrust REIT by 7.5% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,277 shares of the real estate investment trust’s stock worth $116,000 after purchasing an additional 437 shares during the last quarter. Ameritas Investment Partners Inc. raised its stake in shares of Caretrust REIT by 18.2% in the second quarter. Ameritas Investment Partners Inc. now owns 6,329 shares of the real estate investment trust’s stock worth $117,000 after purchasing an additional 975 shares during the last quarter. Pinebridge Investments L.P. raised its stake in shares of Caretrust REIT by 10.7% in the second quarter. Pinebridge Investments L.P. now owns 9,558 shares of the real estate investment trust’s stock worth $177,000 after purchasing an additional 920 shares during the last quarter. Finally, Schroder Investment Management Group purchased a new stake in shares of Caretrust REIT in the second quarter worth approximately $183,000. 91.15% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: This article was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another publication, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this article can be accessed at https://www.thecerbatgem.com/2018/01/16/caretrust-reit-ctre-given-a-19-00-price-target-by-stephens-analysts.html.

About Caretrust REIT

CareTrust REIT, Inc is a self-administered, self-managed real estate investment trust. The Company is engaged in the ownership, acquisition and leasing of healthcare-related properties. It makes investments in healthcare-related real estate assets. As of December 31, 2016, its real estate portfolio included 154 skilled nursing facilities (SNFs), SNF Campuses, assisted living facilities and independent living facilities.

Analyst Recommendations for Caretrust REIT (NASDAQ:CTRE)

Receive News & Ratings for Caretrust REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Caretrust REIT and related companies with MarketBeat.com's FREE daily email newsletter.